Anonymised Mumbai Hospital Group — AI Transformation

Client profile: Mumbai hospital group · 3 hospitals · 800 combined beds · ₹380 crore annual revenue · board mandate in November 2025: "establish an AI strategy before Q2 2026" · CMO + CIO jointly responsible · scattered AI deployments (6 tools, no integration, no measurement) · AI Transformation Partner engagement started January 2026.

What "AI strategy" meant at the start vs the end

At the engagement start, the group had deployed: GPT-4 for patient FAQ chatbot on website (no guardrails, occasional clinical advice generated — NMC compliance risk), an AI content tool for generating social media posts (non-compliant with NMC Section 6 in 40% of outputs on audit), an AI scheduling tool (disconnected from the main appointment system), Google's AI features in Google Ads (Advantage+ creatives — including some that ICG's audit flagged as non-compliant with Google Healthcare Policy), an AI transcription tool for management meetings (useful but not patient-facing), and a Gemini integration the CIO had built that nobody used.

Total AI investment: approximately ₹4.2 lakh/month. Total measurable impact: undetermined. Compliance exposure: moderate (the chatbot and content tool were the primary risks).

The AI Transformation Partner engagement

Month 1–2: AI Audit

• Complete inventory of all AI tools across 3 hospitals
• AIO Intel Tool deployment: baseline citation rate for 180 target queries across 5 specialties (cardiac, maternity, orthopaedic, oncology, ophthalmology) → 4% citation rate (the market baseline)
• Compliance audit of chatbot and AI content tool: 40% non-compliance rate on NMC Section 6 checks
• Competitive citation analysis: 3 competitors cited in 24% of the same target queries

Month 3–6: AI Infrastructure Build

• NMC-compliant chatbot replaced with Beacon 4-Bot (scripted, rule-based, zero AI-generated clinical advice)
• FAQPage schema deployed on all priority pages across 3 hospital websites (231 pages total)
• ReviewedBy schema: named clinical reviewers connected to all clinical content pages
• 40–60 word direct-answer blocks restructured across 180 target FAQ pages
• Named-doctor Person schema with sameAs verification chains for 14 key specialists
• Cost transparency pages for top 5 procedure categories (highest AIO citation type)

Month 7–12: AI Compound

• Monthly AIO Intel Tool reports: citation rate tracked weekly
• AEO content expansion: 2 additional clinical content pages per week (educational carve-out format, NMC compliant)
• Beacon ML audience quality scoring deployed for Google + Meta campaigns
• Agency OS AI narrative: monthly Gemini-powered board report with 3-point strategic recommendation

Outcomes

Month 6 citation rate: 18% (from 4% baseline) — improvement attributable to FAQPage schema + reviewedBy schema + direct-answer restructuring

Month 12 citation rate: 24% (ICG portfolio benchmark: 23%)

Compliance: Zero NMC S6 violations in any AI-generated or AI-assisted content since month 3 of engagement

Board AI strategy report: Delivered at month 12. Covered: (1) AI-powered patient acquisition (AEO/LLM citation infrastructure), (2) AI-driven marketing intelligence (Beacon ML, Agency OS Gemini narrative), (3) Clinical AI readiness advisory (CDSCO SaMD framework for the 2 clinical AI tools the CIO wanted to deploy). The PE fundraising round (Series A extension) included the AI transformation journey as a strategic asset.

CMO's framing at the PE meeting: "Our AI strategy is not about tools. It is about infrastructure. We are now cited in 24% of the patient research queries that matter to our specialties. That is a compounding asset."